SCHEMBL746155

SCHEMBL746155

FCc1cn[c]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2894160 0.73
SCHEMBL971263 0.71
SCHEMBL991144 0.70
SCHEMBL17074430 0.69
SCHEMBL2444699 0.69
SCHEMBL451341 0.67
SCHEMBL971203 0.66
SCHEMBL4990370 0.65 MALT1 (0.33)
SCHEMBL11890123 0.62
SCHEMBL1515054 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3353174-A1 N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL]AMIDES USEFUL AS BACE INHIBITORS Pfizer Inc (US) 2018-08-01 EP claimed
EP-2864324-B1 DIFLUORO-HEXAHYDRO-CYCLOPENTAOXAZINYLS AND DIFLUORO-HEXAHYDRO-BENZOOXAZINYLS AS BACE1 INHIBITORS HOFFMANN LA ROCHE (CH) 2018-03-28 EP claimed
WO-2017051294-A1 N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL] AMIDES USEFUL AS BACE INHIBITORS PFIZER INC. (US) 2017-03-30 WO claimed
US-9181232-B2 Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as BACE1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2015-11-10 US claimed
US-9067926-B2 Fluoromethyl-5,6-dihydro-4H-[1,3]OXAZINES HOFFMANN-LA ROCHE INC. (US) 2015-06-30 US claimed
US-20150133440-A1 DIFLUORO-HEXAHYDRO-CYCLOPENTAOXAZINYLS AND DIFLUORO-HEXAHYDRO-BENZOOXAZINYLS AS BACE1 INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2015-05-14 US claimed
EP-2864324-A1 DIFLUORO-HEXAHYDRO-CYCLOPENTAOXAZINYLS AND DIFLUORO-HEXAHYDRO-BENZOOXAZINYLS AS BACE1 INHIBITORS F. Hoffmann-La Roche AG (CH) 2015-04-29 EP claimed
US-20150031690-A1 FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZINES F. HOFFMANN-LA ROCHE AG (CH) 2015-01-29 US claimed
EP-2807155-A1 FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZINES F.HOFFMANN-LA ROCHE AG (CH) 2014-12-03 EP claimed
WO-2014001228-A1 DIFLUORO-HEXAHYDRO-CYCLOPENTAOXAZINYLS AND DIFLUORO-HEXAHYDRO-BENZOOXAZINYLS AS BACE1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2014-01-03 WO claimed
WO-2013110622-A1 FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZINES F. HOFFMANN-LA ROCHE AG (CH) 2013-08-01 WO claimed
US-20130116230-A1 3-AMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORPORATION (US) 2013-05-09 US claimed
US-8362003-B2 3-aminopyrrolidine derivatives as modulators of chemokine receptors INCYTE CORPORATION (US) 2013-01-29 US claimed
EP-2431357-A2 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors Incyte Corporation (US) 2012-03-21 EP claimed
US-20110251168-A1 3-AMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORPORATION 2011-10-13 US claimed
EP-1565436-A4 3-AMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORP (US) 2007-07-18 EP claimed
US-20060252751-A1 3-Aminopyrrolidine derivaties as modulators of chemokine receptors INCYTE HOLDINGS CORPORATION 2006-11-09 US claimed
JP-2006516145-A 2006-06-22 JP claimed
EP-1565436-A2 3-AMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORPORATION (US) 2005-08-24 EP claimed
WO-2004050024-A2 3-AMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORPORATION (US) 2004-06-17 WO claimed